【结 构 式】 |
【药物名称】Aceclofenac, YT-919, Beofenac, Preservex, Gerbin, Falcon, Airtal 【化学名称】Glycolic acid [2-(2,6-dichloroanilino)phenyl]acetate ester 【CA登记号】89796-99-6 【 分 子 式 】C16H13Cl2NO4 【 分 子 量 】354.19231 |
【开发单位】Almirall Prodesfarma (Originator), Bristol-Myers Squibb (Licensee), Daewoong (Licensee), Gedeon Richter (Licensee), UCB (Licensee), Yakult Honsha (Licensee) 【药理作用】ANALGESIC AND ANESTHETIC DRUGS, Analgesic Drugs, Ankylosing Spondylitis, Treatment of, Antiarthritic Drugs, Osteoarthritis, Treatment of, Rheumatoid Arthritis, Treatment of, TREATMENT OF MUSCULOSKELETAL & CONNECTIVE TISSUE DISEASES, Non-Steroidal Antiinflammatory Drugs |
合成路线1
Alkylation of the sodium salt of diclofenac (I) with benzyl bromoacetate (II) in hot DMF yielded the (arylacetoxy)acetate (III). Subsequent hydrogenolysis of the benzyl ester of (III) in the presence of Pd/C gave the title carboxylic acid. Alternatively, the benzyl ester group of (III) was cleaved by means of the combination of chlorotrimethylsilane and sodium iodide. This method of selective ester hydrolysis with in situ generated iodotrimethylsilane was also applied to the corresponding methyl (IV) and tert-butyl (V) esters. In a related procedure, tert-butyl ester (V) was prepared by alkylation of diclofenac (VI) with tert-butyl bromoacetate (VII) in the presence of tertiary amines. Selective cleavage of the tert-butyl ester group of (V) was then performed by treatment with either trifluoroacetic or formic acid.
【1】 Casas, A.V. (Almirall Prodesfarma, SA); 2-[(2,6-Dichlorophenyl)amino]phenylacetoxyacetyl derivs. and therapeutic compsns. containing same. EP 0119932; US 4548952 . |
【2】 Ginebreda Martí, A.; Agustí Cruz, A. (Almirall Prodesfarma, SA); Process for obtaining 2-[(2,6-dichlorophenyl)amino]phenylacetoxyacetic acid. ES 2020146 . |
【3】 Schickaneder, H.; Nikolopoulos, A.; Murphy, T.; Process for the preparation of aceclofenac. WO 9955660 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56535 | sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate | C14H10Cl2NNaO2 | 详情 | 详情 | |
(II) | 12869 | benzyl 2-bromoacetate | 5437-45-6 | C9H9BrO2 | 详情 | 详情 |
(III) | 56536 | 2-(benzyloxy)-2-oxoethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C23H19Cl2NO4 | 详情 | 详情 | |
(IV) | 56537 | 2-methoxy-2-oxoethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C17H15Cl2NO4 | 详情 | 详情 | |
(V) | 56538 | 2-(tert-butoxy)-2-oxoethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C20H21Cl2NO4 | 详情 | 详情 | |
(VI) | 33701 | Diclofenac; 2-[2-(2,6-Dichloroanilino)phenyl]acetic acid | C14H11Cl2NO2 | 详情 | 详情 | |
(VII) | 17430 | 2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate | 5292-43-3 | C6H11BrO2 | 详情 | 详情 |
合成路线2
Aceclofenac was prepared by selective hydrolysis of other labile ester precursors. Alkylation of diclofenac sodium (I) with tetrahydropyranyl chloroacetate (IX), prepared by protection of chloroacetic acid (VIII) with dihydropyran, furnished the tetrahydropyranyl ester of aceclofenac (X), which was then deprotected by treatment with HCl. Similarly, the preparation of aceclofenac was reported by acidic hydrolysis of the analogous tetrahydrofuranyl ester (XI).
【1】 Flores Ramos, R. (Almirall Prodesfarma, SA); Process for obtaining 2-[(2,6-dichlorophenyl)amino]phenylacetoxy acetic acid. ES 2046141 . |
【2】 Zirngibl, L.; Gnehm, R. (Siegfried AG); Process for the preparation of a phenylacetic acid deriv.. CH 682747 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56535 | sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate | C14H10Cl2NNaO2 | 详情 | 详情 | |
(VIII) | 11847 | 2-Chloroacetic acid; Chloroacetic Acid | 79-11-8 | C2H3ClO2 | 详情 | 详情 |
(IX) | 56539 | tetrahydro-2H-pyran-2-yl 2-chloroacetate | C7H11ClO3 | 详情 | 详情 | |
(X) | 56540 | 2-oxo-2-(tetrahydro-2H-pyran-2-yloxy)ethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C21H21Cl2NO5 | 详情 | 详情 | |
(XI) | 56541 | 2-oxo-2-(tetrahydro-2-furanyloxy)ethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C20H19Cl2NO5 | 详情 | 详情 |
合成路线3
Alternatively, alkylation of diclofenac sodium (I) with either trichloroethyl bromoacetate (XII) of tribromoethyl bromoacetate (XIII) gave rise to the respective trichloroethyl (XIV) and tribromoethyl (XV) esters of aceclofenac. Reductive cleavage of the trihaloethyl esters (XIV) and (XV) using zinc powder under acidic conditions furnished the title compound.
【1】 Frank, A.; Karn, H.; Spanig, H. (Abbott GmbH & Co. KG); Production of 1-hydroxyalkyl-5-nitroimidazoles. DE 2359625; FR 2253019; GB 1481349 . |
【2】 Frank, A.; Dockner, T.; Karn, H. (Abbott GmbH & Co. KG); Process for the preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole of high purity. EP 0150407 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56535 | sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate | C14H10Cl2NNaO2 | 详情 | 详情 | |
(XII) | 56542 | 2,2,2-trichloroethyl 2-bromoacetate | C4H4BrCl3O2 | 详情 | 详情 | |
(XIII) | 56543 | 2,2,2-tribromoethyl 2-bromoacetate | C4H4Br4O2 | 详情 | 详情 | |
(XIV) | 56544 | 2-oxo-2-(2,2,2-trichloroethoxy)ethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C18H14Cl5NO4 | 详情 | 详情 | |
(XV) | 56545 | 2-oxo-2-(2,2,2-tribromoethoxy)ethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C18H14Br3Cl2NO4 | 详情 | 详情 |